Physician profile
Aaron Wood
NPI 1558713339
$1,786.93
in general payments reported to CMS, 2019-2025
15 companies · $406 in 2025
The $406 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $225 · 2020: $127 · 2021: $101 · 2022: $328 · 2023: $196 · 2024: $403 · 2025: $406.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,005.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,005.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $248.67 | 2019-2020 | |
| Lilly USA, LLC | $237.75 | 2022-2025 | Mounjaro |
| Si-Bone, INC. | $229.39 | 2022-2025 | |
| Medtronic, INC. | $194.65 | 2021-2024 | Kyphon Express II Kyphopak Tray |
| Abbott Laboratories | $150.09 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $135.16 | 2022-2023 | Breztri |
| Corcept Therapeutics | $114.14 | 2025 | Korlym |
| Phathom Pharmaceuticals, INC. | $113.09 | 2024 | Voquezna |
| Idorsia Pharmaceuticals US INC | $88.05 | 2023 | Quviviq |
| Novo Nordisk INC | $77.76 | 2019 | |
| Procept Biorobotics Corporation | $69.04 | 2025 | |
| Inspire Medical Systems, INC. | $61.71 | 2024 | Inspire |
| Merck Sharp & Dohme LLC | $41.79 | 2023 | Vaxneuvance |
| Sanofi Pasteur INC. | $13.63 | 2019 | |
| Amgen INC. | $12.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Wood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.